Substance Use Disorder Prevention & Treatment

Massachusetts Health & Hospital Association Substance Use Disorder Prevention and Treatment Task Force


Charge


The Substance Use Disorder Prevention and Treatment Task Force (SUDPTTF) was developed at the direction of the MHA Board of Trustees to develop provider focused strategies to help address the high incidence of opioid misuse that affects our communities. The SUDPTTF is focused on developing operational practices within hospitals and physician practices that would assist in reducing the number of opioid pain prescriptions and result in a corresponding reduction in the number of opioid overdoses that are occurring in Massachusetts.


Task Force Guidelines


Guidelines for Opioid Management within a Hospital Setting

The SUDPTTF has approved and issued a second set of guidelines outlining several provider and operational recommendations related to prescribing opioid and/or opiate medications within a hospital setting, including hospital owned/affiliated clinics or physician practices. The goal is to develop a general standard for limiting the use of or finding alternatives to prescription opioids. We encourage all hospitals to adopt the recommendations. The guidance includes the following materials:

 

Emergency Department Opioid Management Guidelines

The first guidelines developed by the task force impacts opioid prescribing practices within hospital Emergency Departments (ED). The ED Opioid Management Guidelines establish a baseline ED operational practice that will: standardize opioid prescribing practices, provide guidance on screening patients seeking opioid prescriptions, offer information on appropriate pain management and treatment, and help identify resources for patients needing substance use treatment. The overall goal is to better enable ED providers to take an active role in limiting inappropriate access to opioid pain medications. The materials include the following:

Resources


Work Plan


The specific action items of the MHA proposed Substance Use Disorder Task Force will be to consider the following:

1. Develop provider specific medical protocols or other clinical practices that will ensure better outcomes of care for substance use disorder patients after receiving care at a healthcare facility by :

a. improving prescribing practices; and
b. changing internal clinical care protocols within the facility (hospital, clinic, medical home, community health center) related to treatment plans and patient education on the use of opiate prescriptions.

2. Coordinate and share hospital specific best practices/strategies for medical protocols and clinical practices among healthcare providers.

3. Organize subgroups to assist with monitoring and advocating for federal and state regulatory actions that would assist with implementing medical protocols or clinical practices

a. Including but not limited to advocating with public and private payers to remove financial incentives through patient satisfaction measures to prescribe greater opiate prescriptions.

4. Identify and link hospitals with existing state resources, grants, and other funding to assist with developing community education, clinical practices, and operational policies;

MHA Substance Use Disorder Prevention and Treatment Task Force Members

Chairs:     Peter J. Holden, President & CEO, BID Hospital-Plymouth
               Pat Noga, PhD, RN, VP, Clinical Affairs, MHA

Alex Walley, MD, Clinical Addiction Research, Boston Medical Center
Amanda L. Jenkins, MD, Senior Science Director, Quest Diagnostics, Inc.
Carol Plotkin, LICSW, System Director of Behavioral Health, Hallmark Health System
Cheryl Bartlett, RN, Executive Director, CCRSAPI, Cape Cod Healthcare
Douglas Munsey, MD, Medical Director, Behavioral Health Service, Southcoast  Hospitals Group
Edward Boyer, MD, PhD, Emergency Physician & Chief of Medical Toxicology,  UMass Memorial
James S. Gessner, MD, President-Elect, Massachusetts Medical Society
Jeffrey W. Hillis, JD, MBA, President, AdCare Hospital
John M. Connolly, MD, Chief of Anesthesia, Beth Israel Deaconess Hospital-  Plymouth
Julia Lindenberg, MD, Associate Medical Director, Beth Israel Deaconess  Medical Center
Kevin Norton, CEO, Lahey Behavioral Health, Lahey Health System
Melisa Lai Becker, MD, Site Chief of Emergency Medicine, Cambridge Health  Alliance
Michele L. Gougeon, Executive Vice President/Chief Operating Officer, McLean  Hospital
Nalan Ward, MD, Director, Outpatient Addiction Services, Massachusetts General Hospital
Niels K. Rathlev, MD., FACEP, Professor and Chair, Department of Emergency  Medicine, Baystate Medical Center
Robert J. Moura, MS, RPh, FMSHP, Director of Pharmacy Services, Emerson  Hospital
Robert Roose, MD, Chief Medical Officer, Addiction Services, Sisters of  Providence (Mercy)
Sharon Levy, MD, Director, Adolescent Substance Abuse program, Boston  Children’s Hospital
Stephen Ryzewicz, MD, Internist/Academic Hospitalist, Baystate Medical Center
Steven Defossez, MD, EMHL, VP, Clinical Integration, MHA
Tu Anh Ngo, PhD, MPH, Co-Director, Primary Care Behavioral Health, Edith  Nourse Rogers Memorial Veterans Hospital

Home Care Alliance of MA:
Elaine Fluet, President/CEO of GVNA Healthcare, Inc.

MHA Clinical Issues Advisory Council (CIAC):
Terry Sievers, MS, RN, CPHQ, VP, Quality & Patient Safety, Lawrence General Hospital

• MHA Physician Hospital Integration Collaborative (PHIC):
Michael Sheehy, MD, Medical Director for Population Health, Reliant Medical Group
Jacob Kagan, MD, Specialty Director, Behavioral Health, Harvard Vanguard Medical Associates

• MHA Physician Leadership Council (PLC):
Arthur Russo, MD, Vice President Medical Affairs, Harrington Hospital
Richard Weiner, MD, FACS, VP, Medical Affairs, Winchester Hospital and PLC Co-chair

• Organization of Nurse Leaders of MA, RI, NH & CT (ONL):
Timothy Quigley, R.N., Chief Nursing Officer, South Shore Hospital and ONL  Board Member